NCT01287130 2019-12-17AZD6244 With Cetuximab for Solid Tumors and Colorectal CancerNational Institutes of Health Clinical Center (CC)Phase 1 Completed10 enrolled
NCT01217450 2014-05-29Selumetinib and Cetuximab in Treating Patients With Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed33 enrolled